Rosen, leading investor counsel, encourages y-mabs therapeutics, inc. investors to secure counsel before important deadline in securities class action - ymab

New york , feb. 9, 2023 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, reminds purchasers of the securities of y-mabs therapeutics, inc. (nasdaq: ymab) between october 6, 2020 and october 28, 2022, both dates inclusive (the "class period"), of the important march 20, 2023 lead plaintiff deadline. so what: if you purchased y-mabs securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
YMAB Ratings Summary
YMAB Quant Ranking